Causes of death in patients suffering from medullary thyroid carcinoma: Report of 119 cases;Causes de mortalite chez les patients atteints de cancer medullaire de la thyroide

Presse Medicale

Volumn 25, Issue 37, 1996, Pages 1819-1822

  Cohen, R ^a   Buchsenschutz, B ^a   Estrade, P ^a   Gardet, P ^b   Modigliani, E ^a  

^a AVICENNE HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DEATH; ETIOLOGY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; THYROID MEDULLARY CARCINOMA; ADOLESCENT; AGED; CAUSE OF DEATH; CHILD; FACTUAL DATABASE; FRANCE; GENETICS; MEDULLARY CARCINOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CAUSE OF DEATH; CHILD; DATABASES, FACTUAL; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0029846778     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Calmettes C. Le cancer médullaire de la thyroïde: acquis et interrogations. Med Sci 1991; 7:22-9.
2. Raue F, Kotzerke J, Reinwein D et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin Invest 1993; 71:7-12.
3. Rosenberg-Bourgin M, Farkas D, Calmettes C, Feingold N et le GETC. Epidemiologic and genetic analysis of medullary thyroid carcinoma in France. In: Medullary thyroid carcinoma, Calmettes C, Guliana JM eds. Colloque Inserm, John Libbey Eurotext 1991; 211:149-57.
4. Saad MF, Ordoner NG, Rashid RK, et al. Medullary carcinoma of the thyroid: a study of clinical features and prognostic factors in 161 patients. Medicine 1984; 63:319-42.
5. Gharib H, Mc Conahey WM, Tiegs RD et al. Medullary thyroid carcinoma: clinicopathologic features and long term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992; 67:934-40.
6. Parmentier C, Gardet P, De Vathaire F, Travagli JP, Caillou B, Schlumberger M. Pronostic factors in Medullary thyroid carcinoma (MTC): study based on 207 patients treated at the Institut Gustave Roussy. In: Medullary thyroid carcinoma, Calmettes C, Guliana JM eds. Colloque Inserm, John Libbey Eurotext, 1991; 211:193-8.
7. Calmettes C. Création d'un groupe d'étude des tumeurs à calcitonine. Bull Cancer (Paris) 1984; 71:266-73.
8. Schuffenecker I, Billaud M, Catender A et al. RET proto- oncogen mutations in French NEM 2A and FMTC families. Human Mol Genet 1994; 3:1939-43.
9. Rougier P, Calmettes C, Laplanche A et al. The values of calcitonin and carcinoembryonic antigen in treatment and managment of non familial medullary thyroid carcinoma. Cancer 1983; 51:855-62.
10. Barbot N, Schuffenecker I, Calmettes C, Modigliani E, Lenoir G, Bigorgne JC. Conditions actuelles du dépistage du carcinome médullaire du corps thyroïde. Rev Fr Endocrinol Clin 1993; 34:539-48.
11. Cohen R, Modigliani E. Medullary thyroid carcinoma: 25 years on. Cancer J 1993; 6:59-64.
12. Abdelmoumene N, Schlumberger M, Gardet P et al. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 1994; 69:1141-4.